文献速递淋巴瘤

皮肤T细胞淋巴瘤发病机制中的分支演化与基因组瘤内异质性

Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma.
PubMed 文献 · Blood Adv · 2020-01-01

对49例蕈样肉芽肿进行外显子组测序,鉴定出28个既往未报道的推定驱动基因,肿瘤呈现中位6个亚克隆的分支系统发育模式及广泛瘤内异质性,分期进展与瘤内异质性增加及突变从主干向分支重新分布相关,各患者间克隆驱动突变模式高度可变,塞扎里综合征也检出类似瘤内异质性,作者据此提出蕈样肉芽肿分支演化发病模型。

要点

  • 49例蕈样肉芽肿外显子组测序鉴定出28个既往未报道的推定驱动基因。
  • 肿瘤呈现中位6个亚克隆的分支系统发育模式及广泛瘤内异质性。
  • 分期进展与瘤内异质性增加及突变从主干向分支重新分布相关。

核心结论

  • 蕈样肉芽肿可能并非按现行认识的线性方式进展,而是由异质性突变亚克隆组成,作者据此提出包含肿瘤亚克隆分歧演化的发病模型。

研究设计与样本

  • 对49例蕈样肉芽肿病例进行外显子组测序,并分析瘤内异质性与克隆演化模式。

主要发现

  • 鉴定出28个既往未报道的推定驱动基因。
  • 蕈样肉芽肿呈现广泛瘤内异质性,中位6个亚克隆,呈分支系统发育关系模式。
  • 分期进展与瘤内异质性增加及突变从主干向分支重新分布相关。
  • 克隆驱动突变模式高度可变,患者间无一致的突变。
  • 在白血病期皮肤T细胞淋巴瘤(塞扎里综合征)中检出类似的瘤内异质性。

临床怎么用

  • 作者提出蕈样肉芽肿发病模型并讨论瘤内异质性如何影响皮肤T细胞淋巴瘤靶向药物与免疫治疗的疗效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mycosis fungoides (MF) is a slowly progressive cutaneous T-cell lymphoma (CTCL) for which there is no cure. In the early plaque stage, the disease is indolent, but development of tumors heralds an increased risk of metastasis and death. Previous research into the genomic landscape of CTCL revealed a complex pattern of >50 driver mutations implicated in more than a dozen signaling pathways. However, the genomic mechanisms governing disease progression and treatment resistance remain unknown. Building on our previous discovery of the clonotypic heterogeneity of MF, we hypothesized that this lymphoma does not progress in a linear fashion as currently thought but comprises heterogeneous mutational subclones. We sequenced exomes of 49 cases of MF and identified 28 previously unreported putative driver genes. MF exhibited extensive intratumoral heterogeneity (ITH) of a median of 6 subclones showing a branched phylogenetic relationship pattern. Stage progression was correlated with an increase in ITH and redistribution of mutations from stem to clades. The pattern of clonal driver mutations was highly variable, with no consistent mutations among patients. Similar intratumoral heterogeneity was detected in leukemic CTCL (Sézary syndrome). Based on these findings, we propose a model of MF pathogenesis comprising divergent evolution of cancer subclones and discuss how ITH affects the efficacy of targeted drug therapies and immunotherapies for CTCL.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Iyer A, Hennessey D, O'Keefe S, et al. Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma. Blood Adv. 2020. PMID: 32502269. doi:10.1182/bloodadvances.2020001441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。